drugset / Trial / NCT00170729
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective was to demonstrate that two days of treatment with 0.5% prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye.
Timeline
- Start
- 2004-08-17
- Primary completion
- 2005-02-28
- Completion
- 2005-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | 0.5 % | Topical |